CANHR is resolved to end the misuse of psychoactive drugs in nursing homes. This blog is our primary forum for discussing how to change the pro-drugging culture of most nursing homes, physicians and nursing staff. Please help us by sharing your experiences, newsworthy developments and suggestions here.

About the Authors

DPH Report: Multiple Drugging “Failures”

On May 31, the California Department of Public Health released a report summarizing the work of its Antipsychotic Collaborative and making recommendations for addressing the multiple “failures” it identified. The report recounts the myriad regulatory violations it uncovered by reviewing … Continue reading

Share

Add Depakote to Burgeoning List of Illegally Marketed Drugs

by Anthony Chicotel, CANHR Staff Attorney In what has become a disturbingly recurrent pattern, Abbott Labs has agreed to pay $1.6 billion settlement to the federal government and several states for illegally marketing a psychotropic drug as a treatment for … Continue reading

Share

CMS Flip-Flops on Independent Pharmacist Requirements

by Michael Connors, Advocate With great support from CANHR and many other advocates, CMS published regulations in October 2011 proposing to require nursing home consultant pharmacists to be independent from long term care pharmacies. CMS then explained that new requirements … Continue reading

Share

CANHR’s Dementia Care Symposium Coming to So Cal on June 4 and 5!

Registration is now open for “Dementia Care Without Drugs – A Better Approach for Long-term Care Facilities” Following the phenomenal success of similar symposia in central and northern California, CANHR is co-sponsoring back-to-back full day dementia care trainings in San Diego … Continue reading

Share

Alive Inside

By Michael Connors, CANHR Advocate Hard to believe but true, Henry Dreher, a 94 year-old nursing home resident, is the latest internet sensation. Until recently, Henry was increasingly withdrawn and communicated little in the nursing home memory care unit where … Continue reading

Share

Johnson and Johnson Ordered to Pay $1.2 Billion for Mis-marketing Risperdal

by Anthony Chicotel, CANHR Staff Attorney A judge recently ordered Johnson and Johnson to pay the state of Arkansas $1.2 billion for illegally marketing its antipsychotic drug Risperdal. The lawsuit included allegations that Johnson and Johnson illegally marketed Risperdal for … Continue reading

Share

The Kids Ain’t Alright

by Anthony Chicotel, CANHR Staff Attorney The National Center for Youth Law (NCYL) has announced a national project to stop the overuse of psychotropic medications on foster children.  CANHR recently met with the NCYL project leaders and we shared information … Continue reading

Share

DPH Collaborative Issues First Fine for Illegal Drugging

The California Department of Public Health’s (DPH) Antipsychotic Drug Collaborative has issued its first citation and monetary fine against a nursing home for illegally drugging residents with chemical restraints.  The citation was issued against Briarwood Health Care – a nursing home … Continue reading

Share

Medi-Cal Restricts Payments for Antipsychotic Drugs in Nursing Homes

by Michael Connors, CANHR Advocate On October 1, 2011, Medi-Cal implemented a little-publicized new policy requiring skilled nursing facilities to jump through new hoops before Medi-Cal will pay for the use of antipsychotic drugs prescribed for residents. The policy establishes … Continue reading

Share

CMS to Introduce Campaign to Reduce Antipsychotic Use on March 29

by Michael Connors, CANHR Advocate The Centers for Medicare and Medicaid Services (CMS) has announced that it is developing a national action plan to protect nursing home residents from unnecessary antipsychotic drug use and to improve dementia care. CMS is … Continue reading

Share